Arius, Peregrine sales and marketing update

PPHM's Avid Bioservices Inc. subsidiary will manufacture cGMP batches of ARI's cancer stem cell antibody ARH460-16-2. The MAb against CD44 is expected to begin a Phase I trial to treat cancer in 2008...